Perceptive Xontogeny Venture Fund

The Perceptive Xontogeny Venture Fund (PXV Fund) focuses on early-stage life sciences companies, primarily making seed and Series A investments, with a select focus on later-stage financings. Its strategy involves partnering with founders and entrepreneurs, providing operational and strategic support, and investing in differentiated technologies that aim to significantly impact serious diseases or improve healthcare delivery. The fund targets investments in biotechnology, medtech, healthtech, digital health, and healthcare tools/services, with a data-driven approach to advance technologies from preclinical stages through clinical proof-of-concept.